endo-Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid, 95.0%, 1g

2-(2-(Bromomethyl)-4-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

1-Boc-4-Ethynylpiperidine, 95.0%, 5g

Natriumhexanitrocobaltat(III), p.a., ACS, 250 g, kunststoffverpackung.

2-METHOXY-6-(TRIFLUOROMETHYL) PHENYLBORONIC ACID, 95.0%, 250mg

3-((Benzyloxy)methyl)-2-(4-methoxybenzyl)-3,4-dihydro-2H-1,2-thiazine 1,1-dioxide, 98%, 100mg

Benzamide, N-[2-[(3S)-3-[[4-hydroxy-4-[5-(2-pyrimidinyl)-2-pyridinyl]cyclohexyl]amino]-1-pyrrolidinyl]-2-oxoethyl]-3-(trifluoromethyl)-, 98%, 250mg

1-Chloro-4-(ethylthio)benzene, 5g

4-Bromo-6-fluoro-1H-indazole, 95.0%, 5g

2,5-Dibromobenzene-1,4-diol, 95.0%, 5g

tert-Butyl 4-(3-chloropyrazin-2-yl)piperazine-1-carboxylate, 95.0%, 250mg

Methyl 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoate, 97.0%, 250mg

4-chloro-2,7-dimethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine, 95.0%, 2.5g